Background: Coronavirus has been found to interact with and affect the cardiovascular system leading to myocardial damage and cardiac and endothelial dysfunction. Respiratory symptoms are worse in COVID-19 affected patients with pre-existing cardiac ailments; however, new-onset cardiac dysfunction is common in this subset. Most patients with COVID-19 have cardiac symptoms like chest pain, palpitations along respiratory symptoms. Methods: It is a single-center observational study. This study was conducted in tertiary health care from May 2020 to December 2020(9 months) with COVID-19 infection having cardiac symptoms. The patient’s clinical features, electrocardiogram (ECG), Echocardiography, cardiac biomarkers, hematological and biochemical parameters are studied in detail. Result: The mean age of the patients was 48±16 years. Male: Female ratio was 7:3. The percentage of onset of cardiac dysfunction was more in the less than 40year age group compared to other age groups. Nearly 46.7% of people have co-morbidities such as diabetes mellitus, hypertension and COPD. In the study population, elevated levels of biomarkers were noted. Abnormal electrocardiogram and echocardiogram were observed. The recovery rate from COVID-19 with cardiac manifestation was observed to be 76.7% in our study population. Conclusion: Cardiac injury is a common condition among patients hospitalized with COVID-19, and it is associated with a higher risk of in-hospital mortality. A combined evaluation of cardiac biomarkers with ECG and ECHO findings is likely to give a better picture of the severity of cardiac function in newly onset of cardiac dysfunction due to COVID-19 infection for better management and prognosis